IJMS | Free Full-Text | Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Various adjuncts to IVIg help treat coronary artery abnormalities in pediatric Kawasaki disease | MDedge Pediatrics
Figure 1 | Archives of Disease in Childhood
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health
IVIG Treatment for Kawasaki Disease | AmeriPharma™ Specialty
Kawasaki Disease: An Update on Diagnosis and Treatment - ScienceDirect
Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High‐Risk Patients With Kawasaki Disease | Journal of the American Heart Association
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease | Pediatric Annals
Treatment of Kawasaki disease | Download Table
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Frontiers | A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram
The Lancet - Kawasaki disease is a self-limited vasculitis that is the most common cause of acquired heart disease in children in developed countries. Although intravenous immunoglobulin (IVIG) is effective therapy, 10–20%
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease | Semantic Scholar
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials - eBioMedicine
JCI - Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
Flow chart reference for the management of refractory and incomplete... | Download Scientific Diagram
Management of Kawasaki disease | Archives of Disease in Childhood
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health
Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink
Clinical characteristics in Kawasaki disease related to intravenous... | Download Table
Clinical Practice Guidelines : Kawasaki disease
2021 ACR/VF Kawasaki Guidelines - Vasculitis Foundation
Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin | Semantic Scholar
Treatment Options for Refractory Kawasaki Disease
Frontiers | Kawasaki Disease
